PCN82 COST-EFFECTIVENESS OF NIVOLUMAB AS ADJUVANT TREATMENT OF MELANOMA IN ADULTS WITH INVOLVEMENT OF LYMPH NODES OR METASTATIC DISEASE WHO HAVE UNDERGONE COMPLETE RESECTION IN THE ITALIAN SETTING

Abstract

Authors

P. Di Rienzo F.S. Mennini A. Marcellusi C. Bini M. Augusto I. Orsini S. Teitsson A. Amadi